# 3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents

> **NCT02280447** · PHASE1,PHASE2 · COMPLETED · sponsor: **Statens Serum Institut** · enrollment: 240 (actual)

## Conditions studied

- Immunization, Booster

## Interventions

- **BIOLOGICAL:** 1/3 IPV-Al SSI, manufactured by SSI, Denmark
- **BIOLOGICAL:** 1/5 IPV-Al SSI, manufactured by SSI, Denmark
- **BIOLOGICAL:** 1/10 IPV-Al SSI, manufactured by SSI, Denmark
- **BIOLOGICAL:** IPV SSI, manufactured by SSI, Denmark

## Key facts

- **NCT ID:** NCT02280447
- **Lead sponsor:** Statens Serum Institut
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-13
- **Primary completion:** 2015-03
- **Final completion:** 2015-03-05
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02280447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02280447, "3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02280447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*